Iterum Therapeutics plc (ITRM) NASDAQ

0.66

-0.0179(-2.64%)

Updated at September 08 04:00PM

Currency In USD

Iterum Therapeutics plc

Address

Fitzwilliam Court

Dublin, 2

Ireland

Phone

353 1 669 4820

Sector

Healthcare

Industry

Biotechnology

Employees

9

First IPO Date

May 25, 2018

Key Executives

NameTitlePayYear Born
Mr. Corey N. FishmanPresident, Chief Executive Officer & Director1.13M1965
Dr. Michael W. Dunne M.D.Strategic Advisor & Director135,0001960
Ms. Judith M. MatthewsChief Financial Officer677,0351971
Dr. Steven I. Aronin M.D.Senior Vice President & Head of Clinical Development0N/A
Mr. Tom Loughman Ph.D.Senior Vice President of Technical Operations0N/A
Ms. Louise BarrettSenior Vice President of Legal Affairs & Secretary0N/A

Description

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.